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ABSTRACT
Objective: Overweight seems to be related to a higher prevalence of sleep disturbances. Decreased 
sleep duration and altered sleep quality are risk factors for obesity. Our aim was to compare the 
sleep pattern of overweight children with that of a matched control group and assess the relationship 
between sleep quality and obesity. Materials and methods: Retrospective cohort study comparing 
41 overweight children with a normal-weight control group, both submitted to polysomnography. 
The samples were matched for age, sex, and apnea-hypopnea index. Body mass index (BMI) z-scores 
were calculated using World Health Organization (WHO) growth charts. Insulin resistance in the study 
group was determined using the homeostatic model assessment for insulin resistance (HOMA-IR). 
Sleep patterns were compared. The statistical analysis was performed using SPSS® version 21. 
Results: The mean age (± standard deviation) of the population was 10 ± 3.4 years (min. 5 years; 
max. 17 years). Fifty-six percent of the participants in both groups were girls. N3% was lower in 
the study group (18.95 ± 6.18%) compared with the control group (21.61 ± 7.39%; t (40) = 2.156, p = 
0.037). We found a correlation in the study group between HOMA-IR and N3% (Rs = -0.434, p = 0.008). 
Conclusion: The present study suggests a link between overweight/obesity and altered sleep quality 
due to compromised non-rapid eye movement sleep, an indirect marker of sleep quality. There was 
also a link between slow-wave sleep duration and insulin resistance. We must find a strategy to 
provide adequate slow-wave sleep duration to reduce the obesity epidemic at young ages. Further 
research is needed. Arch Endocrinol Metab. 2017;61(3):367-73.
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INTRODUCTION
T he prevalence of childhood overweight and obesity has significantly increased in the past 
decades, representing a global epidemic and a 
major public health concern (1). Childhood obesity 
contributes to significant physical, psychological, and 
economic burden. It often continues into adulthood 
and confers a major risk for insulin resistance, impaired 
glucose tolerance, hypertension, dyslipidemia, and 
cardiovascular disease (2).
Attempted interventions to improve diet and 
physical activity patterns among adolescents have had 
limited success at controlling pediatric obesity (3). 
Identification of early childhood modifiable risk factors 
should be a priority (2,3).
While the prevalence of obesity has increased, 
lifestyle changes have led to a decrease in night sleep 
hours among children and adolescents due to later 
bedtimes with unchanged rise times. Worldwide 
studies estimate that 20%-30% of children and 6%-37% 
of adolescents report problems related to prolonged 
sleep latency, difficulty initiating and maintaining 
sleep, frequent nocturnal awakenings, and poor 
sleep quality accompanied by significant daytime 
impairments (4,5).
Short sleep has been identified as a risk factor for 
obesity in children and adults, and several studies have 
reported a strong relationship between sleep duration 
and higher BMI (2). However, it has been difficult to 
draw immediate conclusions on the consistency of the 
association, direction of causality, and likely mechanisms 
involved (6). 
The underlying pathogenic pathways are complex 
and unresolved, but it is known that sleep, specially 
slow-wave sleep (SWS), has a major role in body 
restorative processes and energy metabolism. Poor 
sleep might impact glucose regulation, inflammatory 
markers, and appetite regulating hormones, promoting 
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food intake (7-9). Although a strong relationship 
between sleep deprivation, increased food intake, and 
obesity has been documented, only a small number of 
studies have yet examined how eating behavior may be 
related to sleep quality and quantity (9,10). It has been 
demonstrated that reduced subjective sleep quality 
scores are associated with behaviors like binge eating 
and emotional eating (11,12).
Other pathogenic mechanisms seem to play a 
role in the relationship between sleep deprivation 
and obesity. The autonomic nervous system is 
an important contributor in coordinating energy 
homeostasis and plays a role in the pathophysiology 
of obesity. Sympathovagal imbalance, a marker of 
autonomic dysfunction, is present in obese children 
with sympathetic hyperactivity and decreased 
parasympathetic functioning when compared 
with normal-weight children (12,13). Autonomic 
dysfunction has been linked to altered sleep duration, 
sleep fragmentation, sleep disorders like insomnia, and 
subjective/objective reports of poor sleep quality (14,15). 
Cross-sectional studies reveal that shorter sleep 
duration, poor sleep quality, sleep disturbances, and 
a delayed sleep phase pattern are associated with 
larger body composition, greater central adiposity, 
and increased obesity rates among adults and youths 
(4,14,16). In addition to these potential consequences, 
short sleep may contribute to increased risk of cognitive 
and behavioral problems (17). 
The aim of the present study was to compare the 
sleep pattern of overweight children with a matched 
control group and assess the relationship between sleep 
quality and overweight/obesity. 
MATERIALS AND METHODS
Study type
Retrospective cohort study comparing 41 overweight 
and obese children (study group) to 41 non-overweight 
children (control group).
Study population
The study population included children and adolescents 
submitted to a sleep study. Children were referred to 
a sleep specialist to exclude sleep disturbances in the 
context of snoring. Overweight and obese children 
were selected to make up the study group. The control 
group was randomly selected from non-overweight 
patients. Both groups were matched for age, sex, and 
apnea-hypopnea index (AHI). 
Measures
Anthropometrics
Children were weighed (to 0.1 kg) with a calibrated 
scale, and their heights were measured (to 0.1 cm) with 
a stadiometer at the first sleep appointment by the same 
observer using the same equipment. The International 
System of Units was used. Weight was measured in 
kilograms (kg) and height in centimeters (cm). BMI 
values were calculated dividing weight (kg) by squared 
height (m2). Age-sex-adjusted BMI standard deviation 
scores (z-scores) were computed and distributed using 
World Health Organization (WHO) growth charts 
and the official WHO z-score calculator. Overweight 
was defined as a BMI z-score > 1 and obesity as a BMI 
z-score > 2. Normal weight was defined as a BMI 
z-score ≤ 1. These definitions were based on WHO 
recommendations (18).
Sleep data by polysomnography
All children underwent nocturnal type 1 
polysomnography (PSG) at our sleep laboratory during 
an acute illness free period. All PSG were performed 
using electroencephalography (frontal, central, and 
occipital channels), chin electromyography, two leg 
channels, electrooculogram, piezo-electric chest and 
abdominal belts, simultaneous pressure transducer and 
thermistor for nasal flow, transcutaneous (Tc) carbon 
dioxide and oxygen saturation monitoring, snore 
microphone, electrocardiography, and simultaneous 
video monitoring. All PSG results were scored by the 
same professional, adequately qualified in PSG analysis 
(with a Master degree in sleep sciences). 
Detailed sleep parameters were measured, including 
total sleep time (TST); wake after sleep onset (WASO); 
non-rapid eye movement sleep (NREM) divided into 
three stages: stages 1 (N1) and 2 (N2), light sleep 
stages, and stage 3 (N3), SWS; rapid eye movement 
sleep (REM) latency; sleep efficiency; REM; SWS 
percentage; snoring percentage; number of arousals 
per hour; AHI and oxygen saturation nadir. Periodic 
leg movements (PLM) and PLM arousal index, and 
parasomnias were also investigated. Sleep architecture 
was scored using the 2012 American Academy of Sleep 
Medicine guidelines (AASM 2012) (19). The following 
definitions were used: 1. Obstructive sleep apnea was 
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defined as the cessation of airflow for two respiratory 
cycles; 2. Hypopnea was defined as a decreased in 
amplitude of the airflow signal by 50% lasting two 
respiratory cycles and accompanied by an oxygen 
desaturation > 3%; 3. An AHI > 1/hr was considered 
as a diagnosis of obstructive sleep apnea syndrome 
(OSAS); 4. Habitual snoring was defined as snoring 
not accompanied by oxygen desaturation, arousals or 
changes in air flow; 5. Periodic limb movements of sleep 
were defined as repetitive jerking of the legs during 
sleep of more than five movements per hour, 0.5–5 sec 
in duration, in clusters of four or more separated by 
5–90 sec intervals; 6. Parasomnias were defined by the 
occurrence of confused arousal, sleepwalking episodes, 
sleep terrors, and nightmare disorders according to the 
International Classification of Sleep Disorders (ICSD), 
2nd edition; 7. TST corresponded to the sum of total 
sleep during stages N1, N2, N3, and REM; 8. WASO 
encompassed the time spent awake after sleep had been 
initiated and before final awakening; 9. Sleep efficiency 
was calculated using the ratio of total minutes of sleep 
(N1 + N2 + N3 + REM) and time spent in bed; 10. 
Sleep latency was defined by the time, in minutes, 
elapsed from lights out to sleep onset; 11. REM latency 
represented the time from the first epoch of sleep to the 
first REM sleep. 
The normal ranges of sleep variables are presented 
in Table 1.
Weekday sleep duration was calculated using parents 
or self-reported usual weekday bedtime and wake time.
Evaluation of insulin resistance using the HOMA-IR
In the study group, night fasting plasma glucose and 
insulin levels were measured in our hospital laboratory. 
Parental consent was obtained for blood sampling 
at the Endocrinology appointment. No laboratory 
results from the control group were available, as these 
are not regular laboratory studies required at a sleep 
appointment.
We evaluated insulin resistance using the homeostasis 
model assessment for insulin resistance (HOMA-IR). 
HOMA-IR was calculated with the equation: HOMA-
IR = fasting insulin (µU/mL) x fasting glucose 
(mg/dL) / 405. The cutoff level to determine insulin 
resistance was 3.16 (20). 
Statistical analyses
Descriptive statistics were computed for all variables. 
Sleep patterns were compared using Student’s t test for 
paired samples and Wilcoxon test. We used Spearman’s 
correlation to correlate the sleep pattern and the 
Table 1. Normal values of sleep pattern on polysomnography (adapted from the American Academy of Sleep Medicine guidelines) and comparison of 
sleep patterns between the control and study groups 
Normal values
Control group Study group Comparison
p*Mean SD Mean SD
Duration (reported, h) - 9.43 1.08 9.26 1.45 0.574
TST (min) > 330 416.41 55.92 426.95 61.62 0.353
WASO (min) - 61.40 48.64 67.07 47.25 0.354
Latency (min) < 30 25.42 26.14 21.07 31.40 0.091
Efficiency (%) > 85 TST 82.95 10.66 82.89 11.84 0.892
AHI (nr/h) < 1 3.00 2.30 2.85 2.01 0.199
Arousals (nr/h TST) < 14 12.27 5.17 12.85 5.82 0.444
N1 (%) 0-5 2.98 2.69 3.38 2.33 0.310
N2 (%) < 55 61.77 8.50 63.95 6.22 0.144
N3 (%) 15-20 21.61 7.39 18.95 6.18 0.037
REM (%) 20-25 13.62 5.47 13.25 4.32 0.726
REM sleep latency (min) < 120 157.95 74.01 161.57 59.03 0.688
Mean SpO
2
 (%) > 95 95.54 2.19 95.59 1.36 -
Min. SpO
2
 (%) > 94 93.12 3.14 92.41 3.41 -
TST: total sleep time; WASO: wake after sleep onset; AHI: apnea-hypopnea index; N1: stage 1 of non-rapid eye movement sleep; N2: stage 2 of non-rapid eye movement sleep; N3: stage 3 of non-
rapid eye movement sleep; REM: rapid eye movement sleep; SpO
2
: peripheral capillary oxygen saturation; SD: standard deviation.
* Statistical comparison of the sleep pattern in the control and study groups.
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HOMA-IR index. All data were analyzed with IBM 
SPSS Statistics 21® software (SPSS, Inc., Chicago, IL). 
We defined a p value of < 0.05 to indicate statistical 
significance. 
RESULTS
Descriptive statistics 
Descriptive data are presented as a percentage for 
discrete variables and as mean (± standard deviation 
[SD]) for continuous variables. 
Each group (study and control) comprised 41 
subjects matched for gender, age, and AHI, who were 
evaluated with PSG. The age of the participants ranged 
from 5 to 17 years (mean 10.95 ± 3.4 years), and girls 
represented 56% of the sample. The mean BMI z-score 
of our control and study groups were -0.25 ± 0.80 and 
2.74 ± 0.56, respectively. Our study group was mostly 
composed of obese children (90.2% with BMI z-scores 
> 2; 9.6% with BMI z-scores > 1 and < 2). 
Means and SDs for measures of sleep are presented 
in Table 1. The mean sleep duration was similar in the 
control and study groups (9.43 h vs. 9.26 h). Mean 
latency was 25.42 and 21.07 minutes in each group, 
respectively. Sleep latency lasted more than 30 minutes 
in 17% of the study group (7 children) and in 24.4% of 
the control group (10 children). Sleep efficiency was < 
85% of the TST in 18 study group children (43.9%) and 
20 control group children (48.8%). SWS proportion was 
under 15% in 12 (29.27%) study cases (control group 
had 10 children – 24.3%) and was higher than 20% in 
18 (43.9%) study cases (control group had 24 cases – 
58.5%). In 97.6% cases in the study group, the REM 
proportion was < 20% (90.2% in the control group). In 
15 study group children (36.6%) and 14 control group 
ones (41.1%), counted arousals were > 14 per hour 
during the PSG. Sleep efficiency was reduced in both 
groups (study group 82.89 ± 11.84%; control group 
82.95 ± 10.66%). The remainder sleep constants were 
normal in both groups. 
In the study group, the mean HOMA-IR was 2.38 
± 1.54, and seven cases fulfilled the criteria for insulin 
resistance.
Comparative statistics
The SWS duration (N3) was lower in our study group 
(study group: 18.95 ± 6.18%; control group: 21.61 ± 
7.39%). A statistically significant difference was found 
comparing SWS in both groups (p = 0.037). No statistical 
differences were found comparing other sleep constants 
(p > 0.05). The comparison in sleep patterns between 
the control and study groups is presented in Table 1.
We found a moderately negative correlation (Rs = 
-0.434) between HOMA-IR and %N3 (p = 0.008). 
Only a low positive correlation was found between 
HOMA-IR and %REM (Rs = 0.348, p = 0.037) and 
number of arousals (Rs = 0.366, p = 0.028). No other 
statistically different correlations were found comparing 
HOMA-IR and sleep variables. The correlation 
between sleep pattern and HOMA-IR in the study 
group is presented in Table 2.
Table 2. Correlation between sleep pattern and HOMA-IR in the study 
group
Study group
Correlation p
TST (min) 0.014 0.933
WASO (min) -0.126 0.463
Latency (min) -0.027 0.875
Efficiency (%) 0.102 0.553
Arousals (nr/h) 0.366 0.028
N1 (%) 0.106 0.540
N2 (%) 0.000 0.999
N3 (%) -0.434 0.008
REM (%) 0.348 0.037
REM sleep latency (min) 0.115 0.505
Mean SpO
2
-0.201 0.239
Min. SpO
2
-0.1 0.562
TST: total sleep time; WASO: wake after sleep onset; AHI: apnea-hypopnea index; N1: stage 1 
of non-rapid eye movement sleep; N2: stage 2 of non-rapid eye movement sleep; N3: stage 3 
of non-rapid eye movement sleep; REM: rapid eye movement sleep; SpO
2
: peripheral capillary 
oxygen saturation; SD: standard deviation.
DISCUSSION
The increasing prevalence of overweight and obesity in 
children and youth is a major public health concern, as 
it is linked to multiple chronic diseases and premature 
mortality. Interventions to improve lifestyle have been 
applied and efforts have been made to understand the 
different pathogeneses of overweight and obesity (1-
3,21).
Growing scientific evidence identifies disturbed 
sleep as a risk factor for obesity in children. In fact, 
duration of sleep and sleep quality seem to be related 
to obesity (22-25). Poor sleep has also been associated 
with increased waist circumference, an index of central 
adiposity (7,15). 
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Most studies used data collected from self-reporting 
questionnaires or sleep diaries and described sleep 
duration without an objective sleep quality analysis.
In our study, the mean sleep duration was similar 
in both groups, with no significant difference found 
between them (9.43 h vs. 9.26 h, p = 0.574), although 
other published studies have found that obese children 
usually sleep less than normal-weight ones (2,4). Sleep 
duration was the only self-given subjective data. As 
known from the literature, sleep reports are found to 
over-report sleep duration. Parents and children were 
directly asked about the time spent in bed during 
weekdays. The self-reported time could be a reason for 
not finding a significant short sleep duration difference 
between the overweight/obese children and the 
normal-weight children.
In our study, TST was short in both groups, but no 
significant difference was found between the groups. 
This may be due to the PSG being performed in a 
hospital room where the first night effect must be taken 
into account. Also, the PSG was performed during a 
weekday. Spruyt and cols. found no significant difference 
in daily TST but described a shorter TST duration on 
weekends in obese children (p = 0.03) (24). 
When analyzing the PSG data from both groups, 
we noticed that sleep efficiency was reduced in both 
(study group 82.89 ± 11.84%; control group 82.95 ± 
10.66%). This may be related to the first night effect 
and a shorter sleep duration. We found no significant 
difference in the number of arousals, a fact that could 
also explain a reduced efficiency.
All other sleep constants were normal in both 
groups, with the exception of N3%. The study group 
had a decreased percentage of SWS, and a statistically 
significant difference was found comparing the SWS 
results in both groups (18.95 ± 6.18% vs. 21.61 
± 7.39%; p = 0.037). SWS is thought to play an 
important role in cerebral restoration and recovery, 
and is involved in maintenance and consolidation of 
sleep (26). Being the most important sleep phase in 
regulating metabolism, selective deprivation of SWS is 
related to insulin metabolism deregulation, increased 
cortisol secretion, and decreased growth hormone 
concentration. Consequently, reduced SWS and sleep 
fragmentation result in disturbed sleep quality and may 
be related to weight gain and z-score elevation due to 
an important change in body metabolism (22,26). 
The literature provides increasing support for 
the pathophysiology of sympathovagal imbalance 
having a contributing role in the association between 
sleep pattern and obesity. SWS has predominantly 
parasympathetic and reduced sympathetic activity. 
Sleep disturbances are associated with higher nocturnal 
arousals, which enhance sympathetic activity leading 
to increases in urinary catecholamine levels, heart 
rate, blood pressure, and sympathovagal imbalance 
among adults and youth (6,13). Although this was not 
observed in our study, maybe due to the small study 
sample, it is known that obese children have a higher 
sympathovagal imbalance (15).
Shortened sleep is reported to support obesogenic 
behaviors with lower levels of physical activity, 
higher food intake, and selection for junk food and 
a carbohydrate-rich diet (9,14,27). This seems to 
be caused by stimulation of neurons of the ventral 
tegmental area related to the reward sensation after 
food intake (28). 
On the other hand, sympathetic stimulation that 
occurs with sleep deprivation might contribute to 
metabolic deregulation (29).
It is well known in the literature that neurobehavioral 
changes associated with puberty have a significant 
influence on sleep organization. The main changes 
include a delayed sleep phase, which involves a tendency 
for later bedtimes and rise times; shorter sleep, which 
is associated with increased levels of daytime sleepiness; 
and irregular sleep patterns, which involve sleeping 
very little on weekdays and sleeping longer during 
weekends to partially compensate for this sleep loss 
(5,17). However, due to the modest size of the sample 
and no access to the participant’s Tanner stages, these 
factors were not taken into account during the statistical 
analyses in the present study.
The mean HOMA-IR in the study group was normal 
(2.38 ± 1.54), but seven cases fulfilled the criteria for 
insulin resistance (HOMA-IR > 3.16). Besides, we 
found a moderately negative correlation (Rs = -0.434) 
between HOMA-IR and %N3 (p = 0.008). These 
data seem to reinforce the already described relation 
between reduced SWS and dysfunctional metabolism. 
We found no relation between HOMA-IR and TST 
and efficiency, as mentioned in previous articles (30).
Puberty is associated with transient insulin resistance, 
which normally resolves by the end of this period. Girls 
are usually more insulin resistant at all Tanner stages 
than boys (30). This was not taken into account in the 
present study due to the limitations cited above (small 
sample size and absent data on Tanner stages).
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We were unable to find other matching published 
data, mostly because the majority of the studies used 
exclusively self-reported questionnaires to evaluate 
sleep quality and no qualitative PSG data. 
Our study has a number of strengths. First, we 
used an objective methodology to assess sleep quality 
using overnight PSG in all patients and no self-reported 
questionnaire on the perception of sleep quality. This is 
an important fact, as the majority of published studies 
do not use these objective data. Second, the study and 
control group were matched for age, sex, and AHI, 
limiting confounders. Third, no self-reported height or 
weight data were used, and BMI was calculated using 
objective values.
The study has some limitations. The sample size 
(41 children in each group) may be a major limitation. 
Although we used objective PSG data, the total weekly 
sleep duration was self-reported, as already described 
above. Although both groups were matched, other 
confounders could exist: ethnic, sexual maturity, chronic 
illness, socioeconomic status, the frequency of snacking 
and other health-related behaviors or nutritional 
habits. Another limitation may be that all the studies 
were performed at the hospital during a single night 
period; therefore, the first night effect must be taken 
into account. The PSG data were validated for the age 
of the population, making the comparison possible. 
Still, many questions need answers to determine 
causality and exact changes in sleep pattern. 
In conclusion, the present study found a preliminary 
support of altered sleep quality in overweight and obese 
children compared with normal-weight ones, with an 
impact on insulin sensitivity and glucose metabolism. 
This matches previously published information. A link 
seems to exist between overweight/obesity and altered 
SWS duration, an indirect marker of sleep quality, related 
to its metabolic and hormonal homeostatic function. 
Strategies providing behavioral sleep interventions and 
adequate SWS duration are a fundamental objective to 
be pursued in order to reduce the obesity epidemic at 
young ages. Adequate sleep duration and good sleep 
quality seem to be low-cost approaches to ensure 
homeostasis and help control increased weight among 
our youth. There is still need for further research 
evaluating the sleep pattern of overweight children and 
youth, analyzing possible confounding factors in larger 
populations. 
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